Mousmee Sharma

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 48

Top Topics

Nitric Oxide Synthase

Top Venues

Future medicinal chemistry

Drug development research

Therapeutic delivery

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Shraddha Chugh, Mousmee Sharma, Garima Chandrasen, Harish Mudila, Parteek Prasher
Synthesis and release studies on amylose-based ester prodrugs of fenamic acid NSAIDs. Therapeutic delivery (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry (2024)
Shraddha Chugh, Mousmee Sharma, Harish Mudila, Parteek Prasher
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs. Therapeutic delivery (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry 16 (8) (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Shraddha Chugh, Mousmee Sharma, Harish Mudila, Parteek Prasher
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs. Therapeutic delivery (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry (2024)
Shraddha Chugh, Mousmee Sharma, Harish Mudila, Parteek Prasher
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs. Therapeutic delivery (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Dialdehyde starch nanoparticles: an emerging material for anticancer drug delivery. Nanomedicine (London, England) (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Layered double hydroxide nanocarriers: potential delivery systems for mefenamic acid. Nanomedicine (London, England) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry (2023)
Tanisqa Mall, Mousmee Sharma, Parteek Prasher
Mucin glycosylation: a potential target for prostate cancer management. Future medicinal chemistry (2023)
Parteek Prasher, Rabab Fatima, Mousmee Sharma
Cationic polysaccharides: emerging drug delivery vehicle across the physiological mucus barrier. Future medicinal chemistry 14 (8) (2022)
Parteek Prasher, Mousmee Sharma, Manav Sharma, Devendra Singh Rawat
C3 regioselectivity: a major constraint in the drug development with imidazo[1,2-<i>a</i>]pyridines. Future medicinal chemistry 14 (21) (2022)
Parteek Prasher, Mousmee Sharma
Benzimidazole-carbamate anthelmintics: Perspective candidates for the anticancer drug development. Drug development research 83 (2) (2022)
Parteek Prasher, Mousmee Sharma
Targeting mucin hypersecretion in COVID-19 therapy. Future medicinal chemistry 14 (10) (2022)
Mousmee Sharma, Parteek Prasher
Selected heterocycles for the development of pyrophosphate mimics. Future medicinal chemistry 14 (17) (2022)
Parteek Prasher, Mousmee Sharma, Sachin Kumar Singh, Monica Gulati, Vandana Patravale, Brian G Oliver, Kamal Dua
Mucoadhesive particles: an emerging toolkit for advanced respiratory drug delivery. Nanomedicine (London, England) 17 (12) (2022)
Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellappan, Gaurav Gupta, Niraj Kumar Jha, Sachin Kumar Singh, Ronan MacLoughlin, Terezinha J A Pinto, Raimar Löbenberg, Kamal Dua
Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future medicinal chemistry 13 (13) (2021)
Parteek Prasher, Mousmee Sharma
Medicinal chemistry of anthranilic acid derivatives: A mini review. Drug development research 82 (7) (2021)
Parteek Prasher, Mousmee Sharma
Mucoadhesive nanoformulations and their potential for combating COVID-19. Nanomedicine (London, England) 16 (28) (2021)
Parteek Prasher, Mousmee Sharma, Peter Richard Wich, Niraj Kumar Jha, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
Can dextran-based nanoparticles mitigate inflammatory lung diseases? Future medicinal chemistry 13 (23) (2021)
Parteek Prasher, Mousmee Sharma
Medicinal chemistry of pyrophosphate mimics: A mini review. Drug development research (2021)
Rabab Fatima, Mousmee Sharma, Parteek Prasher
Targeted delivery of flufenamic acid by V-amylose. Therapeutic delivery 12 (8) (2021)
Parteek Prasher, Rabab Fatima, Mousmee Sharma
Resistant starch: ideal candidate for the enteric coating of NSAIDs? Future medicinal chemistry 13 (17) (2021)
Parteek Prasher, Rabab Fatima, Mousmee Sharma
Therapeutic delivery with V-amylose. Drug development research 82 (6) (2021)
Parteek Prasher, Mousmee Sharma
Nanotechnology-based self-sterilizing surfaces and their potential in combating COVID-19. Nanomedicine (London, England) 16 (14) (2021)
Mousmee Sharma, Parteek Prasher, Meenu Mehta, Flavia C Zacconi, Yogendra Singh, Deepak N Kapoor, Harish Dureja, Dinesh M Pardhi, Murtaza M Tambuwala, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija
Probing 3CL protease: Rationally designed chemical moieties for COVID-19. Drug development research (2020)
Parteek Prasher, Mousmee Sharma
N-acetylgalactosaminyltransferase: a potential target for colorectal adenocarcinoma. Future medicinal chemistry 12 (17) (2020)
Parteek Prasher, Mousmee Sharma
Targeting N-acetylgalactosaminyltransferase for anticancer therapy. Drug development research 82 (1) (2020)
Parteek Prasher, Mousmee Sharma, Samarth Pratap Singh
Drug encapsulating polysaccharide-loaded metal nanoparticles: A perspective drug delivery system. Drug development research 82 (2) (2020)
Parteek Prasher, Mousmee Sharma
"Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzyme. Drug development research 82 (2) (2020)
Parteek Prasher, Mousmee Sharma, Samarth P Singh, Devendra S Rawat
Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review. Drug development research 82 (3) (2020)